Viewing Study NCT06921759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-01-02 @ 1:35 AM
Study NCT ID: NCT06921759
Status: RECRUITING
Last Update Posted: 2025-11-04
First Post: 2025-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Hand and Foot Dermatitis View
Keywords: